Ketamine Therapy Side Effects: Short-Term vs Long-Term
A plain-language look at ketamine therapy side effects — what happens during the infusion, what fades in hours, and what long-term data actually shows. Ketamine therapy side effects fall into two very different buckets: the things you feel in the chair, and the things people worry about years down the road. Those two conversations get blended together constantly — usually by mixing clinical infusion data with recreational-use data. Here's a plain-language breakdown of what fades in hours, what the long-term evidence actually shows, and when a symptom is worth a phone call. Quick Answer Most ketamine therapy side effects are short-term. Dissociation (a temporary altered sense of body and time), nausea, dizziness, sedation, and a brief rise in blood pressure typically peak during the infusion and ease afterward as the medication clears. The FDA prescribing information for esketamine lists dissociation, sedation, nausea, dizziness and blood pressure increase among the effects monitored in clinic ( SPRAVATO label ). Long-term concerns — bladder irritation, dependence, cognitive change — are documented mainly in frequent, high-dose, unsupervised use rather than spaced clinical dosing ( StatPearls ). TL;DR The intense part is the short part. Dissociation and perceptual changes happen during the session and settle as the drug wears off. See what happens during the infusion Nausea and blood pressure are the two effects clinics actively manage. Both are addressed with pre-medication and repeated vitals checks. Review the body-system breakdown Long-term harm signals come from a very different exposure pattern — frequent, high-dose, unmonitored use, not spaced supervised infusions. Read what the long-term data shows The side effect shape differs from antidepressants: brief and episodic versus mild and continuous. Compare the two profiles side by side Screening and monitoring are the real safety mechanism. See what screening covers In This Article What Side Effects Happen During the Infusion? Which Side Effects Last the Rest of the Day? Ketamine Side Effects by Body System What Does Long-Term Ketamine Therapy Data Actually Show? Why Clinical Dosing Changes the Risk Picture How Do Ketamine Therapy Side Effects Compare to Antidepressant Side Effects? When Should You Call Your Clinic? What Monitoring and Screening Reduce Risk? Frequently Asked Questions What Side Effects Happen During the Infusion? The effects you notice during a ketamine infusion are dose-dependent and largely expected — not a sign something has gone wrong. A subanesthetic infusion is designed to produce a mild altered state, and your care team watches your vitals the whole time. Dissociation is a temporary altered sense of your body, surroundings and the passage of time. It is listed among the adverse reactions in the FDA esketamine prescribing information , and it resolves as the medication clears. Commonly reported in-session effects include: Perceptual drift — colors, sound or body weight feeling different than usual Sedation and drowsiness — both listed in FDA labeling for esketamine Dizziness or vertigo — usually most noticeable when sitting up Nausea — often pre-treated with an anti-nausea medication before dosing begins A transient rise in blood pressure and heart rate — ketamine's cardiovascular stimulation is described in the StatPearls ketamine monograph Anxiety at onset — some people feel a brief surge of unease as the effects begin Practical management is unglamorous and effective: an automated blood pressure cuff cycling at set intervals, an anti-emetic given beforehand, dim lighting, eye shades, and a clinician in the room. If blood pressure climbs or anxiety spikes, the infusion rate can be slowed or paused. If you want the full minute-by-minute picture of what happens during an IV ketamine session , that walkthrough covers the setup, the dosing window and recovery. ⚠️ Dissociation can feel strange or disorienting the first time. Tell your clinician the moment it feels like too much — dose and infusion rate are adjustable, and that feedback shapes your next session. Which Side Effects Last the Rest of the Day? Some people feel tired, foggy or slightly unsteady for a few hours after leaving the clinic. That's the main reason driving is off the table for the rest of the day. The FDA label for esketamine instructs patients not to drive or operate machinery until the next day following restful sleep ( SPRAVATO label ), and IV clinics apply a comparable precaution. Same-day effects people describe most often: Grogginess or mental fog that fades with rest Mild headache Appetite changes — food may sound unappealing for a few hours Emotional rawness — feeling open, tender or unusually reflective Vivid dreams that night Your post-infusion checklist: Arrange a ride home before you arrive. A rideshare is acceptable at many clinics; confirm your clinic's policy. Eat something light once nausea has passed. Skip alcohol for the rest of the day. Postpone big decisions and hard conversations until tomorrow. Write down anything that surfaced — it's useful material for integration or therapy. Planning for this is easier when you know it's coming. Our guide to preparing for your first ketamine session covers logistics, fasting instructions and mindset in more detail. Key takeaway: Build your treatment day around an easy evening — a ride, a light meal and no obligations — and most same-day effects pass quietly. Ketamine Side Effects by Body System Sorting side effects by body system is more useful than a flat severity list, because it tells you where a symptom is coming from and who handles it. The table below groups the effects most often discussed in clinical sources. Body system Common effect Typical pattern What the clinic does Neurologic / psychiatric Dissociation, perceptual change, transient anxiety Peaks during dosing, settles after Dose titration, calm setting, clinician present Cardiovascular Rise in blood pressure and heart rate Transient, during and shortly after infusion Repeat vitals checks; screening for uncontrolled hypertension Gastrointestinal Nausea, occasional vomiting During or shortly after infusion Anti-nausea medication before dosing Vestibular Dizziness, vertigo, unsteadiness Short-lived; worst on standing Slow transition from recliner, assisted walking, no driving Cognitive Short-term attention and memory dip Hours, not days, at clinical doses Driving restriction; schedule light tasks Urologic Urinary urgency or discomfort Uncommon at clinical infusion doses Symptom screening at each visit; prompt evaluation Cardiovascular stimulation, emergence phenomena and nausea are all described as recognized ketamine effects in the StatPearls clinical monograph . Dissociation, sedation, dizziness, nausea and blood pressure increase appear in FDA labeling for esketamine. The urologic row deserves its own note. Bladder symptoms are the one category where "mention it next time" isn't good enough — report it the same day. Our ketamine safety and process FAQ covers what intake screening asks about before your first appointment. What Does Long-Term Ketamine Therapy Data Actually Show? Long-term safety is where honesty matters more than reassurance. The serious harms people have read about — bladder damage, liver strain, lasting cognitive change — appear in the literature overwhelmingly in the context of frequent, high-dose, unsupervised use. Ketamine-induced uropathy refers to inflammation and damage to the bladder lining associated with chronic, heavy ketamine exposure. It is described in the clinical literature in connection with long-term ketamine abuse ( StatPearls ), not with spaced therapeutic infusions. Two other long-term considerations are explicitly flagged by regulators for the esketamine formulation: Abuse and misuse potential. The FDA label addresses risk of abuse and misuse, which is why esketamine is dispensed only through a restricted program with in-clinic administration and observation ( SPRAVATO label ). Cognitive effects. Labeling addresses impairment of attention, judgment, thinking, reaction speed and motor skills around dosing — the basis for the driving restriction. Here's the part competing pages often skip: long-term clinical data for repeated ketamine therapy is thinner than the decades of data behind SSRIs. Depression treatment is still an evolving field, and the National Institute of Mental Health describes an ongoing landscape of treatment research rather than a settled one. A clinic that tells you long-term risk is zero is overstating what the evidence supports. A clinic that tells you supervised, spaced dosing looks very different from daily heavy use is describing what the literature actually distinguishes. What that means practically for anyone considering ketamine therapy in Boise or Eagle: Ask how often you'd be dosed and for how long — exposure frequency matters more than any single session Expect bladder and mood symptom screening at every visit, not just at intake Expect maintenance spacing to be reassessed rather than set and forgotten Expect results and tolerability to vary between individuals For a deeper look at the maintenance phase, see our evidence review on the long-term effects of ketamine therapy . Key takeaway: The long-term risk conversation is really a dose-and-frequency conversation — and supervised therapy sits at the opposite end of that spectrum from the use patterns behind the scary headlines. Why Clinical Dosing Changes the Risk Picture Risk from ketamine isn't set by dose alone. It's set by three variables multiplied together: dose × frequency × duration of exposure. A subanesthetic infusion given every few days for a short series, then spaced out, produces a fundamentally different total exposure than heavy daily use. Clinical infusion protocols for depression use low, subanesthetic doses given slowly under monitoring — a range well below anesthetic dosing, as described in the StatPearls ketamine monograph . Recreational use typically involves far larger amounts, taken repeatedly, with no vitals checks, no screening and no one watching for early warning signs. Supervision adds a second layer the math doesn't capture: early detection. A monitored patient who mentions urinary urgency gets evaluated that week. An unmonitored user may not connect the symptom to anything until it's advanced. This is also why the delivery route shapes the experience. Our overview of IV ketamine therapy in Boise and Eagle explains how an infusion allows the dose to be slowed, paused or adjusted in real time — a level of control that at-home or unsupervised dosing doesn't offer. How Do Ketamine Therapy Side Effects Compare to Antidepressant Side Effects? The two profiles differ in shape more than in severity. Ketamine therapy side effects tend to be noticeable but brief and tied to dosing days. Oral antidepressant effects tend to be milder in any given moment but continuous, because you take the medication daily. Factor Supervised ketamine therapy Daily oral antidepressants (e.g. SSRIs like sertraline, SNRIs like venlafaxine) When effects occur During and shortly after dosing sessions Ongoing, any day you take the medication Duration pattern Episodic — tied to treatment days Continuous while on the medication Intensity More noticeable in the moment (dissociation, dizziness) Usually milder moment to moment Weight changes Not a commonly discussed feature of episodic dosing Weight change is a frequently discussed concern with some agents Sexual side effects Not a commonly discussed feature of episodic dosing Commonly raised with prescribers for this drug class Stopping the medication No daily dose to taper Discontinuation symptoms are a recognized reason to taper under supervision Driving restriction Yes, on treatment days Generally no, though sedation can occur Monitoring required Yes — vitals and clinician supervision Periodic prescriber follow-up Neither column is "better." The